Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PD-1 protein and gene expression as prognostic factors in early breast cancer

1 Jan 2020

Abstract excerpt

Background There is a paucity of data on the prognostic value of programmed cell death protein 1 (PD-1) protein and gene expression in early breast cancer (BC) and the present study's aim was to comprehensively investigate it. Methods The study consisted of three parts: a correlative analysis of PD-1 protein and gene expression from an original patient cohort of 564 patients with early BC; a systematic review and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33172959
DOI: 10.1136/esmoopen-2020-001032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PD-1 protein and gene expression as prognostic factors in early breast cancerPMID 33172959Read ↗

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive diseaseSemantic proximity Read ↗

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancerSemantic proximity Read ↗

Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerSemantic proximity Read ↗

Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant settingSemantic proximity Read ↗

Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.Semantic proximity Read ↗

Prognostic molecular markers in early breast cancerSemantic proximity Read ↗

Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohortSemantic proximity Read ↗

Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohortSemantic proximity Read ↗

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarkerSemantic proximity Read ↗

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancersSemantic proximity Read ↗

Clinical utility of gene-expression signatures in early stage breast cancerSemantic proximity Read ↗

Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.